Physician profile
Randall Zuckerman
NPI 1265496947
$4,193.28
in general payments reported to CMS, 2019-2025
12 companies · $2,198 in 2025
The $2,198 reported for 2025 was more than what 83% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $526 · 2020: $47.78 · 2021: $256 · 2022: $275 · 2024: $891 · 2025: $2,198.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,235 · Food and Beverage: $554 · Consulting Fee: $300.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,234.78 |
| Food and Beverage | $553.98 |
| Consulting Fee | $300.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Histosonics, INC. | $2,661.51 | 2024-2025 | |
| Becton, Dickinson and Company | $830.00 | 2019-2025 | |
| Intuitive Surgical, INC. | $164.24 | 2019-2025 | |
| Steelhead Surgical INC | $152.15 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $145.00 | 2019 | |
| Arthrex, INC. | $62.80 | 2021 | |
| Tela Bio, INC. | $47.60 | 2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Ethicon US, LLC | $40.61 | 2021 | |
| Sobi, INC | $33.21 | 2024 | |
| Integra Lifesciences Corporation | $24.00 | 2025 | Duraseal Exact Spinal Sealant System, Codman Hakim, Cusa Clarity |
| Solventum Corporation | $16.65 | 2025 | Prevena, V.A.C.Ulta |
| Covidien LP | $15.51 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Randall Zuckerman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.